A Study to Investigate the Bioequivalence or Relative Bioavailability of Three New Idasanutlin Tablet Variants Following Oral Administration in Participants With Solid Tumors
Clinical trial NCT03362723 · COMPLETED
Trial details
- NCT number
- NCT03362723
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-27
- Primary completion
- 2019-06-11
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.